Timothy Kieffer
Net worth: - $ as of 2026-06-29
Net worth: - $ as of 2026-06-29
Timothy Kieffer is Chief Scientific Officer at Aardvark Therapeutics, Inc. since 2025.
Formerly, Dr. Kieffer was Chief Scientific Officer at Fractyl Health, Inc., Chief Scientific Officer at ViaCyte, Inc. from 2021 to 2022, and Professor at the University of British Columbia.
Dr. Kieffer earned a doctorate from the University of British Columbia.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FRACTYL HEALTH, INC. -.--% | 2025-02-26 | 0 ( -.--% ) | - $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| AARDVARK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2025-05-19 |
| Companies | Position | End |
|---|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Chief Tech/Sci/R&D Officer | 2022-09-30 |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| FRACTYL HEALTH, INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fractyl Health, Inc.
Fractyl Health, Inc. BiotechnologyHealth Technology Develops and sells therapeutics for metabolic diseases, type 2 diabetes and obesity | Health Technology |
Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions